EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Benefit delayed immunosenescence by regulating CD4 + T cells: A promising therapeutic target for aging‐related diseases

Tingting Xia, Ying Zhou, Jiayao An, Zhi Cui, Xinqin Zhong, Tianyi Cui, Bin Lv, Xin Zhao iD, Xiumei Gao

Aging Cell · 2024-10 · 23 (10)

DOI: 10.1111/acel.14317 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging Cell, online erschienen am 18.08.2024. Verfasst von Tingting Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Education Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tia…. Hauptthemen laut MEDLINE: Immunosenescence, CD4-Positive T-Lymphocytes, Aging. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Tianjin Municipal Education Commission Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD4 + T cells play a notable role in immune protection at different stages of life. During aging, the interaction between the body's internal and external environment and CD4 + T cells results in a series of changes in the CD4 + T cells pool making it involved in immunosenescence. Many studies have extensively examined the subsets and functionality of CD4 + T cells within the immune system, highlighted their pivotal role in disease pathogenesis, progression, and therapeutic interventions. However, the underlying mechanism of CD4 + T cells senescence and its intricate association with diseases remains to be elucidated and comprehensively understood. By summarizing the immunosenescent progress and network of CD4 + T cell subsets, we reveal the crucial role of CD4 + T cells in the occurrence and development of age‐related diseases. Furthermore, we provide new insights and theoretical foundations for diseases targeting CD4 + T cell subsets aging as a treatment focus, offering novel approaches for therapy, especially in infections, cancers, autoimmune diseases, and other diseases in the elderly.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunosenescenceCD4-Positive T-LymphocytesAgingHumansAnimals

Stichwörter der Autor:innen

Naïve CD4+T cellsaging‐related diseaseseffector CD4+T cellsimmunosenescencememory CD4+T cells

Autor:innen und Institutionen

  • Ministry of Education Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

ORCID-Profile: Xin Zhao

Förderung

  • National Key Research and Development Program of China
  • Tianjin Municipal Education Commission Research Project

Zitieren

APA

Xia, T., Zhou, Y., An, J., Cui, Z., Zhong, X., Cui, T., Lv, B., Zhao, X., & Gao, X. (2024). Benefit delayed immunosenescence by regulating CD4 + T cells: A promising therapeutic target for aging‐related diseases. Aging Cell, 23(10). https://doi.org/10.1111/acel.14317

Vancouver

Xia T, Zhou Y, An J, Cui Z, Zhong X, Cui T, et al. Benefit delayed immunosenescence by regulating CD4 + T cells: A promising therapeutic target for aging‐related diseases. Aging Cell. 2024;23(10). doi:10.1111/acel.14317

BibTeX
@article{Xia2024,
  author = {Xia, Tingting and Zhou, Ying and An, Jiayao and Cui, Zhi and Zhong, Xinqin and Cui, Tianyi and Lv, Bin and Zhao, Xin and Gao, Xiumei},
  title = {Benefit delayed immunosenescence by regulating CD4 + T cells: A promising therapeutic target for aging‐related diseases},
  journal = {Aging Cell},
  year = {2024},
  volume = {23},
  number = {10},
  doi = {10.1111/acel.14317}
}
Kostenlos starten →